Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,349 | 52 | 99.6% |
| Education | $11.80 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,109 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $848.90 | 12 | $0 (2023) |
| Lilly USA, LLC | $623.18 | 9 | $0 (2024) |
| Amarin Pharma Inc. | $265.18 | 10 | $0 (2021) |
| Ardelyx, Inc. | $124.89 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $119.70 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $88.62 | 1 | $0 (2024) |
| Amgen Inc. | $71.40 | 3 | $0 (2023) |
| PFIZER INC. | $64.68 | 3 | $0 (2021) |
| Exact Sciences Corporation | $45.82 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $349.10 | 5 | Ardelyx, Inc. ($124.89) |
| 2023 | $384.49 | 8 | Lilly USA, LLC ($139.79) |
| 2022 | $493.34 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($226.48) |
| 2021 | $280.63 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($141.91) |
| 2020 | $443.39 | 9 | AstraZeneca Pharmaceuticals LP ($250.08) |
| 2019 | $713.74 | 8 | AstraZeneca Pharmaceuticals LP ($350.33) |
| 2018 | $491.08 | 4 | AstraZeneca Pharmaceuticals LP ($369.31) |
| 2017 | $205.47 | 2 | AstraZeneca Pharmaceuticals LP ($108.63) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $107.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $88.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/22/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $121.35 | General |
| Category: Obesity | ||||||
| 11/08/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.28 | General |
| 05/10/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Oncology | ||||||
| 05/09/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Bone Health | ||||||
| 05/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Oncology | ||||||
| 03/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 03/06/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Bone Health | ||||||
| 12/28/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: DIABETES | ||||||
| 10/20/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $115.98 | General |
| Category: Diabetes | ||||||
| 10/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $77.33 | General |
| Category: DIABETES | ||||||
| 09/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/20/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $107.10 | General |
| Category: Diabetes | ||||||
| 05/24/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: DIABETES | ||||||
| 04/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: DIABETES | ||||||
| 04/08/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Bone Health | ||||||
| 10/05/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/27/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Cardiovascular | ||||||
| 07/23/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiovascular | ||||||
| 07/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 827 | 2,590 | $141,229 | $78,971 |
| 2022 | 21 | 896 | 2,588 | $179,567 | $101,716 |
| 2021 | 23 | 1,198 | 3,296 | $254,444 | $149,957 |
| 2020 | 22 | 1,038 | 2,656 | $303,171 | $125,267 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 528 | $52,800 | $32,221 | 61.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 101 | $14,746 | $9,468 | 64.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 48 | 276 | $8,280 | $7,076 | 85.5% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 34 | 117 | $15,795 | $5,981 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $6,900 | $5,967 | 86.5% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 22 | 43 | $10,406 | $3,760 | 36.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 23 | $6,095 | $3,151 | 51.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 56 | 207 | $7,245 | $2,165 | 29.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 23 | 115 | $2,875 | $1,661 | 57.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 160 | $1,600 | $1,344 | 84.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 43 | $2,150 | $1,025 | 47.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 59 | 301 | $3,010 | $966.21 | 32.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 53 | 53 | $1,855 | $919.29 | 49.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 24 | $2,400 | $876.12 | 36.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 48 | 48 | $1,680 | $799.65 | 47.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $630.00 | $617.40 | 98.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 21 | 21 | $651.00 | $459.90 | 70.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 22 | $1,100 | $234.60 | 21.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 45 | 111 | $555.00 | $120.15 | 21.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 26 | 224 | $224.00 | $93.64 | 41.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 92 | $92.00 | $32.53 | 35.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $140.00 | $30.80 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 536 | $53,600 | $32,576 | 60.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 152 | $22,192 | $14,068 | 63.4% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2022 | 51 | 201 | $27,135 | $12,530 | 46.2% |
About Dr. Thaeer Sawa, MD
Dr. Thaeer Sawa, MD is a General Practice healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2015. The National Provider Identifier (NPI) number assigned to this provider is 1093109241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thaeer Sawa, MD has received a total of $3,361 in payments from pharmaceutical and medical device companies, with $349.10 received in 2024. These payments were reported across 54 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($3,349).
As a Medicare-enrolled provider, Sawa has provided services to 3,959 Medicare beneficiaries, totaling 11,130 services with total Medicare billing of $455,911. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Sterling Heights, MI
- Active Since 03/25/2015
- Last Updated 06/12/2024
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1093109241
Products in Payments
- JARDIANCE (Drug) $953.41
- Vascepa (Drug) $265.18
- BEVESPI AEROSPHERE (Drug) $251.80
- FASENRA (Drug) $233.84
- MOUNJARO (Drug) $223.08
- FARXIGA (Drug) $155.51
- IBSRELA (Drug) $124.89
- ZEPBOUND (Drug) $121.35
- REXULTI (Drug) $119.70
- DALIRESP (Drug) $117.51
- SYMBICORT (Drug) $108.63
- VERQUVO (Drug) $88.62
- EVENITY (Biological) $71.40
- PREMARIN (Drug) $64.68
- Cologuard Collection Kit (Device) $45.82
- TRULICITY (Drug) $17.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Sterling Heights
Hans Schwarz, Dds, DDS
General Practice — Payments: $88,437
Dr. Bassam Kinaia, Dds, DDS
General Practice — Payments: $40,580
Dr. Haifa Mansour, D.d.s., P.c, D.D.S., P.C
General Practice — Payments: $8,175
Dr. Rana Azzo, Dds, DDS
General Practice — Payments: $5,332
Dr. Eric Steiner, D.d.s, D.D.S
General Practice — Payments: $4,345
William Campbell, D.d.s, D.D.S
General Practice — Payments: $2,287